List of Levaquin drug patents

Levaquin is owned by Janssen Pharms.

Levaquin contains Levofloxacin.

Levaquin has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Levaquin are:

  • US6806256
  • US6806256*PED

Levaquin was authorised for market use on 21 October, 2004.

Levaquin is available in solution;oral dosage forms.

The generics of Levaquin are possible to be released after 26 August, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6806256 JANSSEN PHARMS Taste masked liquid pharmaceutical compositions
Feb, 2022

(11 months ago)

US6806256

(Pediatric)

JANSSEN PHARMS Taste masked liquid pharmaceutical compositions
Aug, 2022

(5 months ago)

Drugs and Companies using LEVOFLOXACIN ingredient

Market Authorisation Date: 21 October, 2004

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of LEVAQUIN before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in